Combined Research Orlando Phase I-IV LLC — Orlando, Florida

Combined Research Orlando Phase I-IV LLC is a clinical research site located in Orlando, Florida, United States 32803.

Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.

Combined Research Orlando Phase I-IV LLC has participated in 6 clinical trials with 3 currently active.

Therapeutic areas: COVID-19, Psychosis Associated With Alzheimer's Disease, Alzheimer Disease.

Sponsors: Pardes Biosciences, Inc., Karuna Therapeutics, Inc., a Bristol Myers Squibb company, Eli Lilly and Company.

Sponsor Feasibility Report

Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Combined Research Orlando Phase I-IV LLC?

Combined Research Orlando Phase I-IV LLC has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Combined Research Orlando Phase I-IV LLC conducted?

Combined Research Orlando Phase I-IV LLC has 6 clinical trials on record, with 3 currently active. Their work covers COVID-19, Psychosis Associated With Alzheimer's Disease, Alzheimer Disease.

Is Combined Research Orlando Phase I-IV LLC accredited by Crixeo Health?

Combined Research Orlando Phase I-IV LLC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Combined Research Orlando Phase I-IV LLC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.